ABIOMED, Inc. (ABMD)
-NasdaqGS 21.83 
1.14(4.96%) May 22, 4:00PM EDT|After Hours
:
21.83 0.00 (0.00%) May 22, 4:31PM EDT
| Prev Close: | 22.97 |
|---|
| Open: | 23.04 |
|---|
| Bid: | 21.00 x 1400 |
|---|
| Ask: | 40.00 x 100 |
|---|
| 1y Target Est: | 21.50 |
|---|
| Beta: | 1.75 |
|---|
| Next Earnings Date: | 29-Jul-13 |
|---|
| Day's Range: | 21.75 - 23.15 |
|---|
| 52wk Range: | 11.80 - 24.93 |
|---|
| Volume: | 449,352 |
|---|
| Avg Vol (3m): | 465,648 |
|---|
| Market Cap: | 839.23M |
|---|
| P/E (ttm): | 59.00 |
|---|
| EPS (ttm): | 0.37 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Abiomed to Present at Deutsche Bank 38th Annual Health Care ConferenceGlobeNewswire(Wed, May 22)
- ABIOMED INC Files SEC form 8-K, Change in Directors or Principal OfficersEDGAR Online(Mon, May 20)
- Abiomed to Present at UBS Global Health Care ConferenceGlobeNewswire(Fri, May 17)
- Carmat gets approval to test artificial heart in four countriesat Reuters(Tue, May 14)
- Abiomed price target raised to $28 from $22 at Stephensat theflyonthewall.com(Mon, May 13)
- Abiomed to Present at Bank of America Merrill Lynch 2013 Health Care ConferenceGlobeNewswire(Wed, May 8)
- The Unappreciated Awesomeness at ABIOMEDat Motley Fool(Wed, May 8)
- HMA Matches Earnings, Misses Rev Est.Zacks(Mon, May 6)
- Thoratec Misses Earnings and Rev EstZacks(Mon, May 6)
- 5 Healthcare Stock Earnings Snapshotsat Wall St. Cheat Sheet(Sat, May 4)
- MWI Vet Earnings Beat, Sales MissZacks(Fri, May 3)
- Abiomed Earnings Beat in 4QZacks(Fri, May 3)
- Masimo Matches Earnings Est.Zacks(Fri, May 3)
- Dismal Earnings Miss by OmnicellZacks(Fri, May 3)
- Abiomed to Present at Bank of America Merrill Lynch 2013 Smid Cap ConferenceGlobeNewswire(Fri, May 3)
Key Statistics
| Forward P/E (1 yr): | 37.00 |
|---|
| P/S (ttm): | 5.58 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Mar-14)
: | 0.32 |
|---|
| Quarterly EPS Est
(Jun-13)
: | 0.06 |
|---|
| Mean Recommendation*: | 2.3 |
|---|
| PEG Ratio (5 yr expected): | 3.62 |
|---|
Business Summary
ABIOMED, Inc. provides medical devices in circulatory support and continuum of care in heart recovery to acute heart failure patients. The companys products are designed to enable the heart to rest, heal, and recover by enhancing blood flow ...
View More